BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15304353)

  • 1. Phosphorylated alpha-synuclein in normal mouse brain.
    Hirai Y; Fujita SC; Iwatsubo T; Hasegawa M
    FEBS Lett; 2004 Aug; 572(1-3):227-32. PubMed ID: 15304353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of alpha-synuclein in different brain parts of adult and aged rats.
    Adamczyk A; Solecka J; Strosznajder JB
    J Physiol Pharmacol; 2005 Mar; 56(1):29-37. PubMed ID: 15795473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain.
    Totterdell S; Hanger D; Meredith GE
    Brain Res; 2004 Apr; 1004(1-2):61-72. PubMed ID: 15033420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitination of alpha-synuclein.
    Nonaka T; Iwatsubo T; Hasegawa M
    Biochemistry; 2005 Jan; 44(1):361-8. PubMed ID: 15628878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental models of Parkinson's disease.
    Beal MF
    Nat Rev Neurosci; 2001 May; 2(5):325-34. PubMed ID: 11331916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-synuclein phosphorylation and truncation are normal events in the adult human brain.
    Muntané G; Ferrer I; Martinez-Vicente M
    Neuroscience; 2012 Jan; 200():106-19. PubMed ID: 22079575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein.
    Wakamatsu M; Ishii A; Ukai Y; Sakagami J; Iwata S; Ono M; Matsumoto K; Nakamura A; Tada N; Kobayashi K; Iwatsubo T; Yoshimoto M
    J Neurosci Res; 2007 Jun; 85(8):1819-25. PubMed ID: 17465029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of alpha-synuclein and its significance].
    Nonaka T; Iwatsubo T; Hasegawa M
    Nihon Rinsho; 2004 Sep; 62(9):1623-8. PubMed ID: 15462375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.
    Iwata A; Maruyama M; Akagi T; Hashikawa T; Kanazawa I; Tsuji S; Nukina N
    Hum Mol Genet; 2003 Oct; 12(20):2625-35. PubMed ID: 12928483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein.
    Yavich L; Oksman M; Tanila H; Kerokoski P; Hiltunen M; van Groen T; Puoliväli J; Männistö PT; García-Horsman A; MacDonald E; Beyreuther K; Hartmann T; Jäkälä P
    Neurobiol Dis; 2005 Nov; 20(2):303-13. PubMed ID: 16242637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
    Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
    Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of mRNA coding for alpha-, beta-, and gamma-synuclein in the brains of newborn, juvenile, and adult rats.
    Malatynska E; Pinhasov A; Crooke J; Horowitz D; Brenneman DE; Ilyin SE
    J Mol Neurosci; 2006; 29(3):269-77. PubMed ID: 17085784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
    Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of an alpha-synuclein peptide fragment enhances metal binding.
    Liu LL; Franz KJ
    J Am Chem Soc; 2005 Jul; 127(27):9662-3. PubMed ID: 15998051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates.
    Arawaka S; Sato H; Sasaki A; Koyama S; Kato T
    Acta Neuropathol Commun; 2017 Jun; 5(1):48. PubMed ID: 28619113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.